≡ Ugandan Children Are Among The First To Receive Abbott’s Lower Strength Aluvia (lopinavir/ritonavir) Tablet Part 3
Developed using breakthrough melt-extrusion technology (Meltrexâ¢), the bright lower-strength tablet formulation offer duplicate benefits in place of the untested full-strength tablet but contain 100 mg of lopinavir and 25 mg of ritonavir, as chum to the 200 mg lopinavir and 50 mg ritonavir inside the original tablet.
About Abbott’s Commitment to Fighting […]
